Skip to main content
Find more clinical trials

Amyloid-Positive Registry for Alzheimer's Drug Research

Start: October 2016
End: October 18, 2017
Enrollment: 2000

What Is This Study About?

This registry will be used to identify older adults with cognitive impairment due to Alzheimer's or suspected Alzheimer's who may be interested in participating in drug trials sponsored by Eli Lilly and Company.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: N/A

Must have:

  • Verified cognitive impairment and diagnosed or suspected Alzheimer's disease
  • Existing positive amyloid brain scan or willingness to undergo amyloid brain scan
  • Study partner who has at least weekly contact

Must NOT have:

  • Mini-Mental State Examination score of less than 10
  • Serious or unstable medical condition
  • Current or past participation in another trial of an anti-amyloid or investigational agent

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Avid Radiopharmaceuticals

Collaborator Sponsor

  • Eli Lilly and Company
  • PRA Health Sciences

Source: ClinicalTrials.gov ID: NCT02918539